|
|
Daniel Moro was
Vice President, Polymer Drug Delivery at Access
Pharmaceuticals from September 2000 until October 2005. He
managed various drug delivery projects related to Hydrogel
polymers. He invented and helped to commercialize the
mucoadhesive erodible drug delivery technology (OraDisc™) for
the controlled administration of actives acquired by ULURU
Inc. Previously, Mr. Moro served as Vice President, Operations
for a Division of National Patent Development Corporation (NPDC)
which developed the soft contact lens. Prior to his
operational experience, Mr. Moro spent 20 years at the NPDC as
a senior research scientist and invented and commercialized
several technologies, including a hydrogel burn and wound
dressing and a subcutaneous retrievable drug delivery implant
to treat prostate cancer. This latter technology, a one year
implant has recently been approved by the FDA and sold under
the trademark Vantas. Mr. Moro has over twenty five years
experience of pharmaceutical development and holds nine
patents related to drug delivery applications, four of which
have been commercialized. |
|
